2008, Fraud and Hospitals - Health Care Compliance Brief

DOJ’s FY 2022 False Claims Act Recoveries: A Mixed Bag

Health Law Advisor

FEBRUARY 10, 2023

Lowest Total Recoveries Since 2008 Record-Shattering Number of New Cases Filed Health Care and Life Sciences Cases Continue to Dominate On February 7, 2023, the U.S. The total recoveries in fraud cases brought with respect to the health care and life sciences industries fell to the lowest level since 2009. Indeed, of the more than $2.2

Fraud

Fraud COVID-19 Governance Medicaid

Why Data Analytics are Critical in a Value-Based Care (VBC) Environment

AIHC

NOVEMBER 29, 2023

Hospital reimbursement also changed. In 1983 Medicare shifted to the inpatient Prospective Payment System (PPS) and DRGs (Diagnostic Related Groups) and only paying a limited number of days to the hospital regardless of the actual length of stay.

Medicare

Medicare Medicare Medicaid Medicaid

Why Data Analytics are Critical in a Value-Based Care (VBC) Environment

AIHC

NOVEMBER 29, 2023

Hospital reimbursement also changed. In 1983 Medicare shifted to the inpatient Prospective Payment System (PPS) and DRGs (Diagnostic Related Groups) and only paying a limited number of days to the hospital regardless of the actual length of stay.

Medicare

Medicare Medicare Medicaid Medicaid

What Are The Current Regulatory Changes And Compliance Requirements That ASCs Need To Be Aware Of In Their Billing Practices?

Healthcare IT Today

JUNE 29, 2023

Understanding ASCs Regulatory Changes and Their Billing Practices Outpatient surgery centers (ASCs) perform many surgical procedures outside of hospitals. Medicare Payment Resources CMS implemented an Ambulatory Payment Classification-based payment methodology in 2008.

Compliance

Compliance Medicare Medicare Medical Billing

States and Feds Signal Big Changes to Telehealth Prescribing

Health Law Advisor

MARCH 1, 2023

Last July, the Department of Health and Human Services’ Office of Inspector General (“OIG”) published a Special Fraud Alert detailing high-risk activities conducted by telehealth providers and has, to date, indicted 31 telehealth providers alleging various health care fraud and abuse schemes.

Telemedicine

Telemedicine COVID-19 Fraud Licensing

Health Provider News

Hall Render

JUNE 30, 2023

for physician referral scheme In Los Angeles, hospital CEO pay could be capped Kaiser Permanente ratings affirmed amid healthy financial profile Nurses vote ‘no confidence’ in California hospital administration, board Nursing facility, management company settle physician kickback allegations for $3.8M

US Department of Health and Human Services

US Department of Health and Human Services Nursing Homes Nurses Hospitals

The Wait is Over. Or Is It? DEA’s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways

Health Law Advisor

MARCH 7, 2023

Background on the Ryan Haight Act The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (the “Ryan Haight Act”) made certain amendments to the CSA which established controls on the remote prescribing of controlled substances. 18 U.S.C. § 21 U.S.C. § Will DEA suggest through its guidance any guardrails for the industry to consider?

Telemedicine

Telemedicine COVID-19 FDA Compliance

Guest Post – Second Circuit Rejects Manufacturer’s Plan to Share Cost of Expensive Drug with Medicare Part D Beneficiaries

Drug & Device Law

OCTOBER 10, 2022

Although the drug is not a “cure,” it does “slow[] the decline in quality of life, reduces hospitalization rates, and typically helps patients live longer.” 3 (2008), the court explained that “the word ‘includes,’ when used in a statute, ‘is usually a term of enlargement, and not of limitation.’” Pfizer, Inc. , So far so good.

Medicare

Medicare Medicare FDA Prescription Drug Pricing

CPAP MDL Overinflates Plaintiffs’ Claims

Drug & Device Law

DECEMBER 4, 2023

Basically, CPAP II purported to do precisely what Buckman itself prohibited: using express preemption to limit the “ordinary working” of implied preemption of fraud on the FDA claims. 2008) (applying the rule; rejecting distinction that “this is a ‘no warning’ case as opposed to an inadequate warning case”), aff’d , 321 F. Sinclair v.

Fraud

Fraud FDA Hospitals Doctors

Thinking About the FDA’s Alternative Summary Reporting Program

Drug & Device Law

SEPTEMBER 18, 2023

Pennsylvania Hospital , 1999 WL 1133313, at *3 (Pa. 312 (2008). So, if a plaintiff contends that a defendant abused the ASR program, that is a Buckman -preempted fraud on the FDA claim. Bexis made a successful preemption argument in Greenwood v. Philadelphia Co. 9, 1999), appeal quashed , 750 A.2d 2d 381 (Pa. Medtronic, Inc. ,

FDA

FDA Fraud Governance Compliance

Health Care Compliance Brief

DOJ’s FY 2022 False Claims Act Recoveries: A Mixed Bag

Why Data Analytics are Critical in a Value-Based Care (VBC) Environment

Trending Sources

Why Data Analytics are Critical in a Value-Based Care (VBC) Environment

What Are The Current Regulatory Changes And Compliance Requirements That ASCs Need To Be Aware Of In Their Billing Practices?

States and Feds Signal Big Changes to Telehealth Prescribing

Health Provider News

The Wait is Over. Or Is It? DEA’s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways

Guest Post – Second Circuit Rejects Manufacturer’s Plan to Share Cost of Expensive Drug with Medicare Part D Beneficiaries

CPAP MDL Overinflates Plaintiffs’ Claims

Thinking About the FDA’s Alternative Summary Reporting Program

Stay Connected